Literature DB >> 18214492

[Toxicity of a new moistening agent and preservative in vitro].

K Kasper1, C Kremling, G Geerling.   

Abstract

PURPOSE: The use of preservatives such as benzalkonium chloride (BAC) usually increases the toxicity of pharmaceutical tear substitutes. HP-guar has been recently introduced as a new artificial tear substitute and includes the preservative Polyquad (0.001%), which is considered to be non-toxic. We therefore examined the effect of preserved (cetrimide 0.01%) and unpreserved HPMC (hydroxypropylmethyl cellulose) and HP-guar in dose and time-response experiments in a human corneal and conjunctival epithelial cell culture model.
METHODS: Immortalized human conjunctival and corneal epithelial cells were cultured in 96-well plates at 37 degrees C with 5% CO(2) and exposed to the test solutions. The ATP content was quantified by means of a luminescence-based ATP assay, intracellular esterase activity by double fluorescent viability staining (calcein AM/ethidium homodimer D-1) and cell migration by a colony dispersion assay. All experiments were performed in triplicate and repeated at least once. The significance of differences was determined with an unpaired two-sided t-test.
RESULTS: HPMC with preservative severely reduced the ATP content at all concentrations tested. Unpreserved HPMC, however, showed an inhibition of ATP production only at 100% and good esterase activity. HP-guar with and without preservative were found to reduce ATP activity more than unpreserved HPMC, but the unpreserved solution was found to reduce cellular ATP levels significantly more than the preserved solution.
CONCLUSIONS: The new preservative Polyquad induced significantly less cytotoxicity than cetrimide. However, even unpreserved HP-guar can induce cytotoxicity in vitro, while unpreserved HPMC remains a good alternative tear substitute with low cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18214492     DOI: 10.1007/s00347-007-1640-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  31 in total

1.  Asymptomatic corneal staining associated with the use of balafilcon silicone-hydrogel contact lenses disinfected with a polyaminopropyl biguanide-preserved care regimen.

Authors:  Lyndon Jones; Nancy MacDougall; L Gina Sorbara
Journal:  Optom Vis Sci       Date:  2002-12       Impact factor: 1.973

2.  The dilution of benzalkonium chloride (BAK) in the tear film.

Authors:  Mitchell H Friedlaender; Daphne Breshears; Bahram Amoozgar; Heather Sheardown; Michelle Senchyna
Journal:  Adv Ther       Date:  2006 Nov-Dec       Impact factor: 3.845

Review 3.  The importance of models in glaucoma research.

Authors:  Robert N Weinreb; James D Lindsey
Journal:  J Glaucoma       Date:  2005-08       Impact factor: 2.503

4.  Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome.

Authors:  I Toda; N Shinozaki; K Tsubota
Journal:  Cornea       Date:  1996-03       Impact factor: 2.651

5.  Comparison of MTT and ATP-based assays for the measurement of viable cell number.

Authors:  R D Petty; L A Sutherland; E M Hunter; I A Cree
Journal:  J Biolumin Chemilumin       Date:  1995 Jan-Feb

6.  An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.

Authors:  Ilan Hartstein; Steven Khwarg; Johan Przydryga
Journal:  Curr Med Res Opin       Date:  2005-02       Impact factor: 2.580

7.  Tear film osmolarity: determination of a referent for dry eye diagnosis.

Authors:  Alan Tomlinson; Santosh Khanal; Kanna Ramaesh; Charles Diaper; Angus McFadyen
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

8.  Induction of apoptosis in human corneal epithelial cells in vitro.

Authors:  J M Kim; F Stapleton; M D Willcox
Journal:  Aust N Z J Ophthalmol       Date:  1999 Jun-Aug

9.  Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.

Authors:  P E Andreotti; I A Cree; C M Kurbacher; D M Hartmann; D Linder; G Harel; I Gleiberman; P A Caruso; S H Ricks; M Untch
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

10.  The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix.

Authors:  B K Pilcher; J A Dumin; B D Sudbeck; S M Krane; H G Welgus; W C Parks
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

View more
  4 in total

1.  [Glaucoma and corneal transplantation].

Authors:  G Geerling; M Müller; M Zierhut; T Klink
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  [Chemical and thermal eye burns. Conservatíve and surgical options of a stage-dependent therapy].

Authors:  H G Struck; N F Schrage
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

Review 3.  [Albumin eye drops for treatment of ocular surface diseases].

Authors:  J D Unterlauft; M Kohlhaas; I Hofbauer; K Kasper; G Geerling
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

Review 4.  [Current and experimental treatment approaches for neurotrophic keratopathy].

Authors:  J Alder; S Mertsch; J Menzel-Severing; G Geerling
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.